SCHEMBL19933664

SCHEMBL19933664

O=C(Oc1ccc(-c2cc(-c3ccc(OC(=O)c4cc(Cl)cc(Cl)c4)cc3)ncn2)cc1)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMO O15229 3/20 0.47
HTT P42858 1/20 0.46
CTRC Q99895 1/20 0.45
MAPT P10636 3/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 2/20 0.40
THRB P10828 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
SMO Q99835 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23018685 0.88 CTRC (0.44) KMOHTTCTRCMAPTSMN1; SMN2
SCHEMBL19933606 0.79 SMN1; SMN2 (0.54) HTTMAPTSMN1; SMN2L3MBTL1TP53
SCHEMBL8387961 0.74 CYP1A2 (0.57) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL19933602 0.73 SMO (0.60) KMOMAPTSMO
SCHEMBL19933629 0.73 LDHA (0.48) HTTMAPTSMN1; SMN2L3MBTL1TP53
SCHEMBL21125638 0.73 MAPT (0.48) MAPTSMN1; SMN2TP53MEN1KMT2A
SCHEMBL19933665 0.73 DGAT1 (0.39) CTRCMAPTSMN1; SMN2TP53THRB
SCHEMBL5287967 0.72 PRSS1 (0.55) HTTCTRCMAPTSMN1; SMN2TP53
SCHEMBL19933603 0.71 ACLY (0.45) KMOMAPTHSD17B10ALDH1A1ALOX15
SCHEMBL18573205 0.71 NPC1 (0.59) MAPTHSD17B10SMN1; SMN2L3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507294-B1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-02-24 EP disclosed
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices MERCK PATENT GMBH 2021-01-12 US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 US disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG KMO 1987/4885HTT 837/4885CTRC 3080/4885
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices PARN, PUF60, PARG KMO 1987/4885HTT 837/4885CTRC 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.